Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine.
about
Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale in European patients: comparison with patients from the USA.Attention-deficit/hyperactivity disorder Under Treatment Outcomes Research (AUTOR): a European observational study in pediatric subjects.Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine.A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities.Predictors of relapse or maintenance of response in pediatric and adult patients with attention-deficit/hyperactivity disorder following discontinuation of long-term treatment with atomoxetine.Assessment of effects of atomoxetine in adult patients with ADHD: consistency among three geographic regions in a response maintenance study.Executive Functioning Outcomes Over 6 Months of Atomoxetine for Adults With ADHD: Relationship to Maintenance of Response and Relapse Over the Subsequent 6 Months After Treatment.Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database.
P2860
Q35666242-943E26BB-A9E8-4EF9-9254-31DFAC16C3CAQ36278068-E99CBE39-0DDF-4D1E-B2F4-290FB78C6B51Q36757388-4FA6204C-1D7B-4BA4-A256-754C357ED5F4Q37638740-8E338548-1F6D-44A6-A20B-5DAA592C13ADQ38801087-F35632D8-4057-4235-9735-A5D546440F06Q39036913-D1BEDED2-6BC7-45A4-9051-407C481182DAQ39493220-C9A0BA8E-D258-43CB-A7E5-EDD35251B66AQ46121131-8E36FABB-62EA-4C48-B2C3-B8424E1D4110
P2860
Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Baseline characteristics of Eu ...... atment study with atomoxetine.
@en
type
label
Baseline characteristics of Eu ...... atment study with atomoxetine.
@en
prefLabel
Baseline characteristics of Eu ...... atment study with atomoxetine.
@en
P2093
P2860
P356
P1476
Baseline characteristics of Eu ...... atment study with atomoxetine.
@en
P2093
Albert J Allen
Alexandra Kutzelnigg
David Williams
Himanshu Upadhyaya
Jody Arsenault
Lenard A Adler
Miguel Casas
Rodrigo Escobar
Yoko Tanaka
P2860
P2888
P356
10.1186/1753-2000-7-14
P577
2013-05-06T00:00:00Z
P5875
P6179
1039275796